Inlet Private Wealth
ABBV icon

Inlet Private Wealth’s AbbVie ABBV Stock Holding History

Inlet Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.77M Sell
14,411
-10
-0.1% -$2.56K 0.91% 36
2026
Q2 		$3.63M Sell
14,421
-380
-3% -$81.8K 0.88% 38
2026
Q1 		$3.22M Sell
14,801
-1,600
-10% -$355K 0.82% 42
2025
Q4 		$3.75M Sell
16,401
-600
-4% -$137K 0.87% 40
2025
Q3 		$3.94M Buy
17,001
+47
+0.3% +$9.6K 0.89% 37
2025
Q2 		$3.15M Hold
16,954
– – 0.77% 41
2025
Q1 		$3.55M Hold
16,954
– – 0.92% 39
2024
Q4 		$3.01M Buy
16,954
+487
+3% +$89.5K 0.8% 44
2024
Q3 		$3.25M Hold
16,467
– – 0.83% 43
2024
Q2 		$2.82M Buy
16,467
+500
+3% +$82.8K 0.77% 42
2024
Q1 		$2.91M Sell
15,967
-10
-0.1% -$1.72K 0.81% 42
2023
Q4 		$2.48M Sell
15,977
-400
-2% -$58.3K 0.76% 41
2023
Q3 		$2.44M Sell
16,377
-13,047
-44% -$1.92M 0.8% 46
2023
Q2 		$3.96M Buy
29,424
+411
+1% +$60.3K 1% 30
2023
Q1 		$4.62M Sell
29,013
-300
-1% -$45.9K 1.2% 25
2022
Q4 		$4.74M Sell
29,313
-366
-1% -$56.1K 1.22% 23
2022
Q3 		$3.98M Buy
29,679
+401
+1% +$57.5K 1.19% 26
2022
Q2 		$4.48M Sell
29,278
-93
-0.3% -$14.2K 1.28% 24
2022
Q1 		$4.76M Buy
29,371
+215
+0.7% +$31.2K 1.19% 23
2021
Q4 		$3.95M Buy
29,156
+67
+0.2% +$7.91K 0.96% 39
2021
Q3 		$3.14M Hold
29,089
– – 0.84% 45
2021
Q2 		$3.28M Buy
29,089
+44
+0.2% +$4.96K 0.86% 46
2021
Q1 		$3.14M Buy
29,045
+2,019
+7% +$216K 0.9% 45
2020
Q4 		$2.9M Buy
27,026
+2,150
+9% +$207K 0.95% 40
2020
Q3 		$2.18M Hold
24,876
– – 0.85% 42
2020
Q2 		$2.44M Buy
24,876
+121
+0.5% +$10.7K 0.97% 39
2020
Q1 		$1.89M Buy
24,755
+2,300
+10% +$196K 0.87% 41
2019
Q4 		$1.99M Buy
22,455
+5,273
+31% +$438K 0.66% 46
2019
Q3 		$1.3M Buy
17,182
+2,000
+13% +$137K 0.48% 62
2019
Q2 		$1.07M Buy
15,182
+200
+1% +$15.7K 0.38% 72
2019
Q1 		$1.21M Buy
14,982
+7,100
+90% +$581K 0.49% 61
2018
Q4 		$727K Buy
+7,882
New +$693K 0.39% 63

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Inlet Private Wealth's ABBV Position: Q3 2026 in Review

Inlet Private Wealth reduced its AbbVie (ABBV) stake by 0.07% in Q3 2026, selling an estimated $2.56K and leaving 14,411 shares worth $3.77M. The position accounts for 0.91% of the portfolio, ranked #36.

Inlet Private Wealth first reported a position in ABBV in Q4 2018 and has held it in 32 quarters since. The position peaked at $4.76M in Q1 2022. 1,137 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Inlet Private Wealth held 14,411 shares of AbbVie worth $3.77M as of Q3 2026.
  • Inlet Private Wealth sold 10 AbbVie shares in Q3 2026, an estimated $2.56K.
  • AbbVie made up 0.91% of Inlet Private Wealth's portfolio in Q3 2026, its #36 holding.
  • Inlet Private Wealth first reported a position in AbbVie in Q4 2018 and has held it in 32 quarters since.
  • Inlet Private Wealth's AbbVie position peaked at $4.76M in Q1 2022.
  • 1,137 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Inlet Private Wealth's 13F filing for Q3 2026, filed 21 Oct 2026.